Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia

This randomized clinical trial examines the safety, efficacy, and feasibility of intranasal insulin for the treatment of persons with mild cognitive impairment and Alzheimer disease dementia.
Source: JAMA Neurology - Category: Neurology Source Type: research